Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Anatomy of the Isthmus, Unraveling the Tissue Composition of the Ventricular Tachycardia Diastolic Pathway

  • Bisbal, Felipe|||0000-0002-4843-7063
  • Aranyó, Júlia
  • Iraola-Picornell, Georgina
  • Sanchez-Quintana, Damian
  • Martínez-Falguera, Daina|||0000-0002-9439-0542
  • Sarrias, Axel|||0000-0001-6712-3097
  • Fadeuilhe, Edgar|||0000-0003-0079-224X
  • Bazán, Víctor|||0000-0001-8072-7434
  • Teis, Albert|||0000-0002-4820-0736
  • Rodriguez-Leor, Oriol|||0000-0003-2657-5657
  • Villuendas-Sabaté, Roger|||0000-0001-9110-905X
  • Curiel, Carolina
  • Armengol, Maria Pilar
  • Pey, Irina
  • Roura, Santiago|||0000-0003-4063-9661
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
Background: A protected, slow-conducting diastolic pathway (isthmus) is the electrophysiological hallmark of post-myocardial infarction (MI) re-entrant ventricular tachycardia (VT). Contemporary evaluations of the histologic composition promoting slow, protected conduction during VT are lacking. Objectives: The goal of this study was to compare the histologic characteristics of confirmed VT isthmuses (VTIs) and non-isthmus scar (NIS) in a chronic MI swine model. Methods: One month after non-reperfused anterior MI, nine Landrace X Large White pigs with inducible VT underwent high-density activation mapping to define the diastolic corridor. Radiofrequency lesions were created to guide the ex vivo VTI localization. Tissue transverse samples from the labeled VTI and NIS were obtained for further histologic, immunohistochemical, and RNA-sequencing expression analyses. Results: Compared with NIS, VTI showed significantly higher fatty infiltration (P = 0.012) and lower levels of collagen I (P = 0.053), collagen III (P = 0.043), and collagen volume fraction (P = 0.027); there were no differences in overall fibrotic deposition. VTI exhibited greater vascular density compared with NIS (P = 0.018), with arteries and veins primarily surrounded by preserved cardiomyocytes. Compared with NIS, viable cardiomyocytes and fibroblasts in VTI displayed higher densities of connexin 43 and connexin 40 (P = 0.022 and P = 0.004, respectively), despite no differences in cardiac troponin I, sarcoplasmic/endoplasmic reticulum Ca2-ATPase 2, or vimentin expression. Thirty-six genes, involving pathways related to extracellular matrix remodeling, inflammation, and immune response modulation, were differentially expressed between VTI and NIS. Conclusions: The VTI exhibits a distinct histologic composition and differential gene expression compared with the surrounding NIS. Mid-diastolic activation sites showed increased adipocytic deposition, vascularization, and connexin expression, along with lower levels of collagen I, collagen III, and collagen volume fraction.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Determination of HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in heart failure patients

  • Rudilla, Francesc|||0000-0002-3099-067X
  • Gastelurrutia, Paloma|||0000-0001-6974-9210
  • Enrich, Emma|||0000-0001-9183-1333
  • Campos, Eva
  • Lupón, Josep|||0000-0002-5601-9611
  • Santiago Vacas, Evelyn|||0000-0001-7511-406X
  • Querol, Sergi|||0000-0002-1105-8633
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
Aims: Cell therapy can be used to repair functionally impaired organs and tissues in humans. Although autologous cells have an immunological advantage, it is difficult to obtain high cell numbers for therapy. Well-characterized banks of cells with human leukocyte antigens (HLA) that are representative of a given population are thus needed. The present study investigates the HLA allele and haplotype frequencies in a cohort of heart failure (HF) patients. Methods and results: We carried out the HLA typing and the allele and haplotype frequency analysis in 247 ambulatory HF patients. We determined HLA class I (A, B, and C) and class II (DRB1 and DQB1) using next-generation sequencing technology. The allele frequencies were obtained using Python for Population Genomics (PyPop) software, and HLA haplotypes were estimated using HaploStats. A total of 30 HLA-A, 56 HLA-B, 23 HLA-C, 36 HLA-DRB1, and 15 HLA-DQB1 distinct alleles were identified within the studied cohort. The genotype frequencies of all five HLA loci were in Hardy-Weinberg equilibrium. We detected differences in HLA allele frequencies among patients when the etiological cause of HF was considered. There were a total of 494 five-loci haplotypes, five of which were present six or more times. Moreover, the most common estimated HLA haplotype was HLA-A*01:01, HLA-B*08:01, HLA-C*07:01, HLA-DRB1*03:01, and HLA-DQB1*02:01 (6.07% haplotype frequency per patient). Remarkably, the 11 most frequent haplotypes would cover 31.17% of the patients of the cohort in need of allogeneic cell therapy. Conclusions: Our findings could be useful for improving allogeneic cell administration outcomes without concomitant immunosuppression.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Ex vivo assessment and in vivo validation of non-invasive stent monitoring techniques based on microwave spectrometry

  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
  • Arauz-Garofalo, Gianluca|||0000-0001-5166-6054
  • Rodriguez-Leor, Oriol|||0000-0003-2657-5657
  • Soler-Botija, Carolina|||0000-0002-4584-9134
  • Amorós García de Valdecasas, Susana
  • Gerez-Britos, Flavio David
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • O'Callaghan, Juan Manuel|||0000-0002-2740-0202
  • Macià, Ferran|||0000-0001-5972-4810
  • Tejada, Javier|||0000-0001-9246-5566
Some conditions are well known to be directly associated with stent failure, including in-stent re-occlusion and stent fracture. Currently, identification of these high-risk conditions requires invasive and complex procedures. This study aims to assess microwave spectrometry (MWS) for monitoring stents non-invasively. Preliminary ex vivo data are presented to move to in vivo validation. Fifteen mice were assigned to receive subcutaneous stent implantations (n = 10) or sham operations (n = 5). MWS measurements were carried out at 0, 2, 4, 7, 14, 22, and 29 days of follow-up. Additionally, 5 stented animals were summited to micro-CT analyses at the same time points. At 29 days, 3 animals were included into a stent fracture subgroup and underwent a last MWS and micro-CT analysis. MWS was able to identify stent position and in-stent stenosis over time, also discerning significant differences from baseline measures (P < 0.001). Moreover, MWS identified fractured vs. non-fractured stents in vivo. Taken together, MWS emerges as a non-invasive, non-ionizing alternative for stent monitoring. MWS analysis clearly distinguished between in-stent stenosis and stent fracture phenomena.